Ado-trastuzumab emtansine Intravenous and Sandostatin LAR Depot injection
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Sandostatin LAR Depot injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Sani-Supp
- Ado-trastuzumab emtansine Intravenous-Sani-Supp rectal
- Ado-trastuzumab emtansine Intravenous-Sansert
- Ado-trastuzumab emtansine Intravenous-Santyl
- Ado-trastuzumab emtansine Intravenous-Saphris
- Ado-trastuzumab emtansine Intravenous-Sapropterin
- Sandostatin LAR Depot injection-Adox Pak 2/100
- Sandostatin LAR Depot injection-Adoxa
- Sandostatin LAR Depot injection-Adoxa CK
- Sandostatin LAR Depot injection-Adoxa Pak
- Sandostatin LAR Depot injection-Adoxa Pak 1/100
- Sandostatin LAR Depot injection-Adoxa Pak 1/150